The physiological reduction in maximal muscle force and power that occurs inevitably with advancing chronological age, clinically termed sarcopenia. This decline is a fundamental component of the aging phenotype, impacting functional independence and metabolic health significantly. It represents a quantifiable measure of musculoskeletal system degradation over time.
Origin
This concept originates from gerontology and exercise physiology, where the term sarcopenia, derived from Greek sarx (flesh) and penia (loss), was coined to describe the syndrome of muscle loss. Within the hormonal health space, its origin is linked to the endocrinology of aging, specifically the somatopause and andropause/menopause.
Mechanism
The primary mechanism involves a shift in the protein synthesis-to-degradation balance, coupled with a progressive denervation of muscle fibers and selective atrophy of fast-twitch (Type II) fibers. Diminished anabolic hormone signaling, including reduced testosterone, estrogen, and growth hormone/IGF-1 axis activity, accelerates this process. Mitochondrial dysfunction and chronic low-grade systemic inflammation also contribute substantially to the compromised muscular integrity and function.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.